Wogonoside induces autophagy-related apoptosis in human glioblastoma cells

Li Zhang1, Handong Wang1, Zixiang Cong1

  • 1Department of Neurosurgery, Jinling Hospital, School of Medicine, Nanjing University, Nanjing, Jiangsu 210002, P.R. China.

Oncology Reports
|June 28, 2014
PubMed

Insights

Wogonoside, a flavonoid from Scutellaria baicalensis, effectively kills glioblastoma cells by inducing apoptosis and autophagy. Autophagy blockade reduces its anticancer effect, suggesting wogonoside

Area of Science:

  • Pharmacology
  • Molecular Biology
  • Oncology

Background:

  • Wogonoside is a flavonoid from Scutellaria baicalensis with preclinical anticancer activity.
  • Its effects on glioblastoma, a type of malignant glioma, are not well understood.

Purpose of the Study:

  • To investigate the effects of wogonoside on human glioblastoma cells.
  • To elucidate the mechanisms underlying wogonoside's potential anticancer activity in glioblastoma.

Main Methods:

  • Cell viability assays were performed on glioblastoma cells treated with wogonoside.
  • Mitochondrial apoptosis, autophagy markers (LC3 dots, AVO formation, p62 degradation), and signaling pathways (MAPK, PI3K/AKT/mTOR) were analyzed.
  • Autophagy was inhibited using chemical inhibitors and RNA interference to assess its role.

Main Results:

  • Wogonoside demonstrated significant cytotoxic effects on human glioblastoma cells.
  • Cell death was primarily mediated by the induction of mitochondrial apoptosis.
  • Wogonoside treatment promoted autophagy, evidenced by increased LC3 puncta, AVO formation, and p62/LC3 turnover.
  • Inhibition of autophagy diminished the anticancer efficacy of wogonoside.
  • The p38 MAPK and PI3K/AKT/mTOR pathways, along with ROS, were implicated in wogonoside-induced apoptosis and autophagy.

Conclusions:

  • Wogonoside exhibits anticancer properties against human glioblastoma cells.
  • The compound induces apoptosis and enhances autophagy, with autophagy playing a crucial role in its efficacy.
  • Wogonoside-induced autophagy and apoptosis involve the p38 MAPK, PI3K/AKT/mTOR pathways, and ROS.
  • Wogonoside warrants further investigation as a potential therapeutic agent for malignant glioma.

Related Concept Videos

Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
3.3K
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
12.0K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.2K
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...
80
Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized...
3.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K